Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxil CR vs Wellbutrin XL in High-Risk MDD
NCT01748955Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jun 2010
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paroxetine, bupropion in major depressive disorder (MDD), suicidal ideation, sponsored by New York State Psychiatric Institute. Started Jun 2010; status: completed.
02
Drugs
paroxetinebupropion
03
Conditions
major depressive disorder (MDD)suicidal ideation
Beyond the preview
Go deeper on NCT01748955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01748955.